Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection

Influenza is a highly contagious, acute, febrile respiratory infection that can have fatal consequences particularly in individuals with chronic illnesses. Sporadic reports suggest that intravenous immunoglobulin (IVIg) may be efficacious in the influenza setting. We investigated the potential of hu...

Full description

Bibliographic Details
Main Authors:	Steven Rockman, Sue Lowther, Sarina Camuglia, Kirsten Vandenberg, Shirley Taylor, Lou Fabri, Sylvia Miescher, Martin Pearse, Deborah Middleton, Stephen J. Kent, Darryl Maher
Format:	Article
Language:	English
Published:	Elsevier 2017-05-01
Series:	EBioMedicine
Subjects:	Influenza Passive immunotherapy Intravenous immunoglobulin IVIg Plasma Serum Antibody
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417301536

Similar Items

The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01)

Potential intravenous immunoglobulin-induced optic disc edema
by: Anna K. Britton, et al.
Published: (2022-09-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
by: Jason Kieffer, MD, et al.
Published: (2024-03-01)

Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
by: Dorota Kwapisz, et al.
Published: (2023-07-01)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
by: Tsvetelina Velikova, et al.
Published: (2023-03-01)

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients
by: Rui Zhang, et al.
Published: (2023-06-01)

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
by: Saori Fukui, et al.
Published: (2021-07-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)

Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
by: Parisa Hajjari, et al.
Published: (2022-08-01)

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study
by: Yan Chen, et al.
Published: (2022-01-01)

Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report
by: Masaru Yanagihashi, et al.
Published: (2020-08-01)

Prescribing Practices of Intravenous Immunoglobulin in Tertiary Care Hospitals in Malaysia: A Need for a National Guideline for Immunoglobulin Use
by: Jian Lynn Lee, et al.
Published: (2022-06-01)

Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
by: Cristina Meregalli, et al.
Published: (2021-01-01)

Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
by: Jorge Adrian Masso-Silva, et al.
Published: (2022-10-01)

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review
by: Paolo Manganotti, et al.
Published: (2023-04-01)

Intravenous immunoglobulin remain a source of bias in the interpretation of infectious disease serology among clinicians
by: A.K. Van der Bij, et al.
Published: (2020-12-01)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020-04-01)

Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy
by: Mohamad Mroué, et al.
Published: (2024-01-01)

Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
by: Colin Anderson-Smits, et al.
Published: (2023-05-01)

Immunoglobulin replacement therapies in inborn errors of immunity: a review
by: Archan Sil, et al.
Published: (2024-02-01)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
by: Elena E. Perez, et al.
Published: (2021-07-01)

Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature
by: Megan Harmon, et al.
Published: (2023-09-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

Binding Performance of Human Intravenous Immunoglobulin and 20(S)-7-Ethylcamptothecin
by: Yong-Chun Liu, et al.
Published: (2018-09-01)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020-11-01)

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS
by: Lidija Kareva
Published: (2016-12-01)

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up
by: Gonzalez Henrik, et al.
Published: (2012-07-01)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
by: Parwinder K. Gill, et al.
Published: (2018-08-01)

Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin
by: Takanori Suzuki, et al.
Published: (2023-07-01)

Intravenous Immunoglobulin and its Complications
by: I Mohammadzadeh
Published: (2011-05-01)

"High Doses Intravenous Immunoglobulin versus Oral Cyclosporine in the Treatment of Severe Atopic Dermatitis "
by: "Mohammad Hassan Bemanian, et al.
Published: (2005-09-01)

The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID)
by: Rohan Ameratunga, et al.
Published: (2019-07-01)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
by: Yusuke Iizuka, et al.
Published: (2017-07-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation
by: Soran Peshbahar, et al.
Published: (2022-01-01)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
by: E. Sedlin, et al.
Published: (2023-04-01)